Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis

by Nikolaos Dimisianos, Maria Rodi, Dimitra Kalavrizioti, Vasileios Georgiou, Panagiotis Papathanasopoulos, Athanasia Mouzaki
Published 2014-01-01

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.

by Athanasia Mouzaki, Maria Rodi, Nikolaos Dimisianos, Andreas Emmanuil, Dimitra Kalavrizioti, Rosa Lagoudaki, Nikolaos C Grigoriadis, Panagiotis Papathanasopoulos
Published 2015-01-01

Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.

by Athanasia Mouzaki, Maria Rodi, Nikolaos Dimisianos, Andreas Emmanuil, Dimitra Kalavrizioti, Rosa Lagoudaki, Nikolaos C Grigoriadis, Panagiotis Papathanasopoulos
Published 2016-01-01

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens

by Maria Rodi, Nikolaos Dimisianos, Anne-Lise de Lastic, Panagiota Sakellaraki, George Deraos, John Matsoukas, Panagiotis Papathanasopoulos, Athanasia Mouzaki
Published 2016-08-01